Skip to main content
Fig. 2 | BMC Complementary Medicine and Therapies

Fig. 2

From: Fumigaclavine C ameliorates liver steatosis by attenuating hepatic de novo lipogenesis via modulation of the RhoA/ROCK signaling pathway

Fig. 2

FC improves hepatic steatosis in high-fat diet (HFD)-induced obese mice. A The time course of body weight within HFD-induced and FC administration. B The liver weight was examined. C The liver/body weight ratio was calculated. D-F The levels of hepatic TC, TG, and LDL-c were detected. TC, total cholesterol; TG, Triglyceride; LDL-c, low density lipoprotein-cholesterol. Simvastatin (Sim, 40 mg/kg) acted as the positive control group. Each value represents as means ± S.E.M. of triplicate experiments. # P < 0.01 as compared with the control group. * P < 0.05, ** P < 0.01, and *** P < 0.001 as compared with the HFD-induced group

Back to article page